Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Rapid Micro Biosystems

Explore full profile

Innovative products for fast, accurate, and efficient detection of microbial contamination in the manufacture of pharmaceuticals, biologics and biotechnology products

Lowell, United StatesFounded 2006Biotech & Life Sciences
Valuation $106M Market cap · 2026
Revenue $39M Latest reported FY
Total funding $100–500M Disclosed equity funding

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc. is an innovative life sciences technology company specializing in automation solutions that streamline the manufacturing and expedite the release of healthcare products. The company serves large and complex pharmaceutical manufacturing operations, focusing on biologics, vaccines, cell and gene therapies, and sterile injectables. Rapid Micro Biosystems operates in the life sciences and healthcare market, providing mission-critical automation solutions that modernize microbial quality control (MQC) testing workflows. The company's flagship Growth platform automates these traditionally manual processes, enhancing efficiency and safety in product release. The business model revolves around selling and supporting its automation platforms, generating revenue through product sales, maintenance contracts, and service agreements. Keywords: automation, life sciences, healthcare, microbial quality control, pharmaceutical, biologics, vaccines, cell therapy, gene therapy, sterile injectables.

Source: Dealroom company data

At a glance

Founded
2006
Headquarters
Lowell, United States
Listing
IPO 2021
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning Rapid Micro Biosystems.

See all news

Investors

19 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Series B and later13 investors entered at this stage

  • Hepalink
  • Bain Capital
  • Xeraya Capital
  • Endeavour Vision
  • Ally Bridge Group
  • Bain Capital Life Sciences
  • Kennedy Lewis Investment Management
  • T. Rowe Price
  • Advent International
  • BlackRock
  • Adage Capital
  • Trinity Capital
  • Armistice Capital
Employees mapped 203 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
12 countries with
team presence
🇺🇸 United States83.2%
🇩🇪 Germany4.7%
🇫🇷 France3.4%
🇯🇵 Japan1.3%
🇬🇧 United Kingdom1.3%
Top 5 of 12 shown
Web traffic by country
6.6K monthly visits
across markets
🇺🇸 United States59.1%
🇯🇵 Japan15.2%
🇮🇳 India13.6%
🇳🇬 Nigeria7.6%
🇨🇭 Switzerland3%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Rapid Micro Biosystems on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rapid Micro Biosystems on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.